Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2610 of 5804
-
New drug combo takes on Hard-to-Treat cancers
Disease control Recruiting nowThe primary objectives of this trial are to: * Characterize the safety and tolerability of TEV-56278 * Determine the Recommended Phase 2 Dose (RP2D) * Evaluate antitumor activity of TEV-56278 (Part 2 only) * Determine the safety and tolerability of TEV-56278 in combination with …
Phase: PHASE1 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Grape compound resveratrol tested in teens with diabetic kidney disease
Disease control CompletedBackground: Food-derived compounds have been shown to have beneficial effects in type 1 diabetes mellitus (T1DM). Among these compounds, resveratrol (3,5,4'-trihydroxystilbene) which is found in grapes, peanuts, cranberries. Resveratrol has a wide range of effects including antim…
Phase: PHASE2, PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Real-World data reveals how HAE drugs perform in chinese patients
Disease control CompletedThe Chinese health authority has approved lanadelumab to prevent Hereditary Angioedema (HAE) attacks in persons of 12 years and older. It has also approved icatibant to treat acute HAE attacks in persons 2 years and older. One of the main aims of this study is to learn about the…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can early comfort care boost quality of life for blood cancer patients?
Symptom relief Recruiting nowPatients with multiple myeloma experience a wide range of physical and psychological symptoms from the time of their diagnosis. Meanwhile, patients with aggressive lymphomas undergo unpredictable illness courses, resulting in goals of care conversations occurring late in the illn…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New drug BL-B16D1 enters first human trial for Hard-to-Treat cancers
Disease control Recruiting nowThis study is an open, multicenter, dose-escalation and expansion-enrollment and nonrandomized phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of BL-B16D1 in locally advanced or metastatic solid tumors.
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:36 UTC
-
Could a simple supplement soothe diabetic nerve damage?
Symptom relief Recruiting nowThe goal of this clinical trial is to find out if a new supplement called Normast® 3 can help reduce nerve pain and improve nerve function in adults with diabetic polyneuropathy (DPN). DPN is a common complication of diabetes that damages nerves, often causing burning, tingling, …
Phase: NA • Sponsor: University of Roma La Sapienza • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New cocktail of cancer drugs tested for tough bladder tumors
Disease control OngoingThis study is a substudy being conducted under one pembrolizumab umbrella master study KEYMAKER-U04. The substudy will consist of 2 parts. Part 1 will evaluate the safety and preliminary efficacy of sacituzumab tirumotecan plus enfortumab vedotin (EV). Part 2 will be based on Par…
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can pacing ease long COVID exercise struggles? study tests a simple strategy
Symptom relief CompletedThis is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key …
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Can a virtual program help kids with asthma and weight? new study tests online vs. In-Person care
Disease control Recruiting nowThe goal of this study is to evaluate the effectiveness of CHAMPION ("Comparative-effectiveness of a Healthy lifestyle and Asthma Management Program, In-person vs ONline"), a primary care-based intervention to address childhood obesity and asthma, and test the effectiveness of a …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Robot-Assisted Weight-Loss surgery may cut pain, study hopes
Symptom relief Recruiting nowThis will be a prospective, obesity-registry based, single-blind randomized controlled trial with a 1:1 allocation ratio. Specific inclusion criteria are all patients eligible to undergo a Laparoscopic sleeve gastrectomy (LSG) based on the current National Institute of Health (NI…
Phase: NA • Sponsor: Ricard Corcelles • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could stem cells ease debilitating pancreas pain?
Symptom relief Recruiting nowThis protocol aims to test whether an infusion of allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs) can reduce pain associated with chronic pancreatitis (CP) and explore potential mechanisms of MSC action.
Phase: EARLY_PHASE1 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Silent suffering: new tool could help spot hip pain in kids who Can't speak
Diagnosis Recruiting nowThe goal of this clinical trial is twofold: 1. to develop a questionnaire for care givers to assess hip pain in quadriplegic pediatric patients who are not able to communicate it independently 2. to validate this questionnaire in a cohort of 100 pediatric patients with quadriple…
Phase: NA • Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Gut check: could sauerkraut and fiber help fight cancer?
Knowledge-focused Recruiting nowThis pilot trial will study the potential impact of two distinct dietary interventions with sequential use of high-fermented foods and high-fiber supplements on the gut microbiome and antitumor immunity in patients with melanoma and non-small cell lung cancer (NSCLC) treated with…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Scientists decode myeloma DNA to personalize future treatments
Knowledge-focused Recruiting nowThis will be a 2 year study to evaluate and improve cancer sequencing as applied to the characterization of tumor molecular make-up and the identification of novel therapeutics (total n=100; approximately 50/year). Participants who will undergo tumor biopsy for management of mult…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New study tests eltrombopag safety in kids with rare bone marrow failure
Disease control Recruiting nowThis is a multicenter, single-arm, non-interventional study (NIS) to confirm the safety and efficacy of eltrombopag in Anti-Thymocyte Globulin (ATG) treatment naive pediatric patients with aplastic anemia (AA).
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Shake it off: vibration training may boost metabolism in obese teens
Disease control Recruiting nowThe main aim of the present study is to evaluate in a group of adolescents with obesity, hospitalized for a period of integrated metabolic rehabilitation (calorie restriction, aerobic physical activity, psychological counseling, nutritional re-education) lasting 3 weeks, the effe…
Phase: NA • Sponsor: Istituto Auxologico Italiano • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New asthma drug tested in kids: could fasenra help?
Disease control OngoingThe purpose of the investigation is to confirm the followings under the post-marketing actual use of Fasenra® Subcutaneous Injection 30 mg / 10mg Syringe (hereinafter referred to as Fasenra). 1. Development of unexpected related AEs\* 2. To grasp development of related AEs\* in …
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Simple supplements may fight fatigue in advanced lung disease
Symptom relief CompletedThe hypothesis that is being tested is that the supplementation of L-arginine plus Vitamin C to multidisciplinary pulmonary rehabilitation (PR) in patients with a previous diagnosis of chronic obstructive pulmonary disease (COPD) and chronic respiratory failure can have a favorab…
Phase: NA • Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Yoga may boost brain health in heart failure patients
Symptom relief ENROLLING_BY_INVITATIONMild cognitive impairment is highly prevalent in patients with heart failure and results in poor well-being and quality of life. While yoga has proven effective in promoting cognitive health in older adults through its gentle movements, controlled breathing, and meditation, its e…
Phase: NA • Sponsor: Auburn University • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Morning vs. evening calories: which wins for weight loss?
Disease control Recruiting nowThe goal of this randomized controlled trial is to learn how the time of day when calories are eaten affects weight loss in the long-term (12 months). The main aims are to learn: 1. The influence of time-based energy intake goals on longer-term weight loss. 2. The influence of t…
Phase: NA • Sponsor: The University of Tennessee, Knoxville • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC